Mozaffarian
Dariush Mozaffarian, Boston, MA US
Patent application number | Description | Published |
---|---|---|
20130267599 | USE OF TRANS-PALMITOLEATE IN IDENTIFYING AND TREATING METABOLIC DISEASE - The present invention provides for a novel lipokine, trans-C16:1n7-palmitoleate, which also serves as a biomarker for metabolic status. More specifically, low concentrations of trans-C16:1n7-palmitoleate the serum indicates a risk of metabolic disease. Additionally, administering trans C16:1n7-palmitoleate to a subject (via pharmaceutical, nutraceutical, or other means), positively impacts glucose metabolism. | 10-10-2013 |
Ehsanollah Mozaffarian, Uttenreuth DE
Patent application number | Description | Published |
---|---|---|
20110208764 | AUTOMATIC STUDY LINKING FOR HYBRID IMAGING - A method and an apparatus are disclosed for automatically linking at least two medical studies which are associated to different acquisition modalities (CT/PET) and which are subject of post-processing in the context of hybrid imaging. In a preparation phase of at least one embodiment, there is defined a classification scheme according to pre-definable rules, conditions and attributes. In an execution phase for a selected source study of a first modality there is looked for at least one target study of a second modality of the same type according to the rules. Then, the source study is automatically linked to the at least one target study. | 08-25-2011 |
Neelufar Mozaffarian, Seattle, WA US
Patent application number | Description | Published |
---|---|---|
20090110667 | DETECTION AND TREATMENT OF AUTOIMMUNE DISORDERS - Disclosed herein are methods of treatment of autoimmune diseases such as systemic lupus erythematosus (SLE) as well as clinical assays for detection of autoimmune disease activity in patients utilizing the involving a PD1 ligand. | 04-30-2009 |
Neelufar Mozaffarian, Mercer Island, WA US
Patent application number | Description | Published |
---|---|---|
20120130350 | DETECTION AND TREATMENT OF AUTOIMMUNE DISORDERS - Disclosed herein are methods of treatment of autoimmune diseases such as systemic lupus erythematosus (SLE) as well as clinical assays for detection of autoimmune disease activity in patients utilizing a PD1 ligand. | 05-24-2012 |
20130195894 | DETECTION AND TREATMENT OF AUTOIMMUNE DISORDERS - Disclosed herein are methods of treatment of autoimmune diseases such as systemic lupus erythematosus (SLE) as well as clinical assays for detection of autoimmune disease activity in patients utilizing a PD1 ligand. | 08-01-2013 |
Neelufar Mozaffarian, La Jolla, CA US
Patent application number | Description | Published |
---|---|---|
20150266954 | IL-21 ANTIBODIES - The invention relates to engineered, humanized antibodies that have high binding affinity for and neutralize human IL-21, methods of using the antibodies to treat conditions in which antagonism or neutralization of the effects of IL-21 is warranted, such as autoimmune conditions, compositions and methods for recombinantly producing the antibodies, and pharmaceutical compositions comprising the antibodies. | 09-24-2015 |